Skip to main content
African Journal of Urology

Table 1 Comparing oncological outcome after 2-year and 3-year follow-up

From: RAZOR trial: analysis of 3-year follow-up: an era of robotic radical cystectomy: is it a new beginning?

Oncological outcome

2-year follow up

3-year follow up

Progression free survival

72·3% in RARC vs

71·6% in ORC

(p-0.9, Pnoninferiority-0.001)

68.4% in RARC vs

65.4% in RARC (p-0.6)

Overall survival

NR

73.9% in RARC vs

68.5% in ORC (p-0.334)

  1. RARC robot-assisted radical cystectomy, ORC Open radical cystectomy, NR not reported
Back to article page